Genpharmasec

Genpharmasec Assets per Share

The Total Assets per Share of Genpharmasec (531592.BO) as of Oct 30, 2026 is 1.44 INR. In the previous year, Total Assets per Share was 1.28 INR — a change of 12.33% (higher).

Assets per Share

1.44INR

YoY

12.33%

Last updated:

Total Assets per Share of Genpharmasec is 2025 1.44 INR. Total Assets per Share of Genpharmasec was 2024 1.28 INR. It decreases by 12.33% higher compared to the previous year.

The Genpharmasec Assets per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Assets per Share
Date
Assets per Share
Jan 1, 2018
0.00 INR
Jan 1, 2019
0.39 INR
Jan 1, 2020
0.45 INR
Jan 1, 2021
0.50 INR
Jan 1, 2022
0.39 INR
Jan 1, 2023
0.36 INR
Jan 1, 2024
1.28 INR
Jan 1, 2025
1.44 INR
The Genpharmasec Assets per Share history
YEARAssets per ShareYoY
1.44INR+12.33%
1.28INR+257.86%
0.36INR-8.20%
0.39INR-22.18%
0.50INR+12.37%
0.45INR+14.09%
0.39INR+13,624.46%
0.00INR-72.99%
0.01INR+803.28%
0.00INR+24.87%
0.00INR-75.18%
0.00INR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Genpharmasec Stock analysis

What does Genpharmasec do? Genpharmasec Ltd. generates revenue through the manufacturing and trading of organic and inorganic chemicals, dyes, and pigments, with key products including potassium hydroxide and caustic soda. The company operates in two main segments: the distribution of diagnostic equipment and investment and trading in securities. Its primary customers are businesses requiring chemical products for industrial applications, while the diagnostic equipment segment serves healthcare providers needing medical devices. The securities trading segment targets institutional investors seeking financial market participation. The company's chemical products are sold to industrial clients across various sectors, leveraging its manufacturing capabilities for potassium hydroxide and caustic soda. Diagnostic equipment distribution caters to healthcare institutions requiring specialized medical tools, while securities trading involves active market participation for financial gains. These segments collectively drive the company's revenue streams without relying on external partnerships or third-party services. Revenue is derived from direct sales of chemical products, distribution of diagnostic equipment, and trading activities in securities. The firm's operational focus remains on chemical manufacturing and trading, diagnostic equipment distribution, and securities investment, with no mention of additional revenue sources or external dependencies in its business description. Genpharmasec is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genpharmasec stock

Total Assets per Share of Genpharmasec is 1.44 INR in 2025.

Total Assets per Share of Genpharmasec changed from 1.28 INR to 1.44 INR, representing a 12.33% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Total Assets per Share Genpharmasec since 2006 – with annual values, charts, and detailed analysis.

Assets per share divides total assets by shares outstanding, indicating the total resource base backing each share of stock.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Other — Genpharmasec

All Key Metrics — Genpharmasec